Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

Details for Australian Patent Application No. 2009245838 (hide)

Owner Halozyme, Inc.

Inventors Frost, Gregory I.; Bookbinder, Louis H.; Kundu, Anirban

Agent Pizzeys

Pub. Number AU-A-2009245838

Parent 2004218354

Filing date 8 December 2009

Wipo publication date 7 January 2010

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/00 (2006.01)

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/47 (2006.01) Medicinal preparations containing peptides

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 1/00 (2006.01) General processes for the preparation of peptides

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C12N 9/24 (2006.01) Enzymes, e.g. ligases (6.) - acting on glycosyl compounds (3.2)

C12N 9/26 (2006.01) Enzymes, e.g. ligases (6.) - acting on alpha-1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase

C12N 11/08 (2006.01) Carrier-bound or immobilised enzymes

C12N 11/10 (2006.01) Carrier-bound or immobilised enzymes

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

24 December 2009 Complete Application Filed

7 January 2010 Application Open to Public Inspection

  Published as AU-A-2009245838

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009245839-Method and Apparatus for Operating Gaming Devices

2009245837-Quinazolinones as potassium channel modulators